Browse Drug Recalls
1,309 FDA drug safety recalls.
FDA Drug Recall Enforcement Database
Browse 1,309 FDA drug recall enforcement actions. Each entry includes the product description, reason for recall, classification (Class I through III based on severity), recalling firm, and distribution details. Use the filters below to search by year, classification, state, or keyword.
Drug Safety Recalls
Browse 1,309 FDA drug recalls in 2014.
| Date | Product | Reason | Class | Firm |
|---|---|---|---|---|
| Jan 31, 2014 | ROYAL PHARMACEUTICALS Derma-Smoothe/FS fluocinolone acetonide 0.01% (Scalp Oi... | Subpotent Drug: The active ingredient, fluocinolone acetonide, was found to be subpotent during t... | Class III | Hill Dermaceuticals, Inc. |
| Jan 29, 2014 | Oxcarbazepine Tablets, 300 mg, 100 tablet bottles, Rx Only. Distributed by: ... | Failed Tablet Specifications: Broken Tablets Present. | Class II | Caraco Pharmaceutical Laboratories Ltd. |
| Jan 29, 2014 | Triamcinolone Acetonide Cream USP, 0.1%, Net Wt 80 grams per tube, Rx only, E... | Labeling: Label Error on Declared Strength: There is a misprint on the end flap which read 01% ra... | Class III | Fougera Pharmaceuticals Inc. |
| Jan 29, 2014 | GREENSTONE BRAND fluconazole for Oral Suspension, ORANGE FLAVORED, 40 mg/mL, ... | Defective Container: Tamper evident ring failures discovered on some bottles. | Class II | Pfizer Inc. |
| Jan 28, 2014 | Carisoprodol Tablets, USP, 350 mg, unit dose blister packages of 100 tablets ... | Failed Impurity/degradation Specification | Class III | Mylan Institutional, Inc. (d.b.a. UDL Laborator... |
| Jan 28, 2014 | Hydroxyprogesterone Caproate 250mg/ml in Sesame Oil, 1 ml injectable solution... | Crystallization; visible crystals from the active ingredient formed due to extreme cold temperatu... | Class II | RX South LLC DBA RX3 Pharmacy |
| Jan 28, 2014 | Metformin HCl Extended-Release Tablets, USP, 500 mg, Rx only, 500 count bott... | Presence of Foreign Tablet; customer complaint of some tablets of Gabapentin found in a bottle of... | Class II | Caraco Pharmaceutical Laboratories, Ltd. |
| Jan 27, 2014 | Suprax, Cefixime for Oral Suspension USP, 500 mg/5 ml, 20 mL (when reconstit... | Failed Impurities/Degradation Specifications: Product did not meet specification in total impurit... | Class III | Lupin Pharmaceuticals Inc. |
| Jan 27, 2014 | Suprax, Cefixime for Oral Suspension USP 500 mg/5 ml, 10mL (when reconstitute... | Failed Impurities/Degradation Specifications: Product did not meet specification in total impurit... | Class III | Lupin Pharmaceuticals Inc. |
| Jan 24, 2014 | Teva Hydroxyzine Pamoate Capsules, USP, 100 mg, 100- count bottle,Rx only, Di... | CGMP Deviations: Hydroxyzine Pamoate Capsules, USP, 100 mg were manufactured using an unapproved ... | Class II | Teva Pharmaceuticals USA |
| Jan 24, 2014 | Fruta BIO 400 mg capsules, supplied in 30 count boxes, distributed by MyNicKn... | Marketed Without an Approved NDA/ANDA: Product was found to contain undeclared active pharmaceuti... | Class I | MyNicNaxs, Inc. |
| Jan 24, 2014 | Meizitang Strong Version Botanical Slimming, Soft Gel Capsules, 650 mg, suppl... | Marketed Without an Approved NDA/ANDA: Product was found to contain undeclared active pharmaceuti... | Class I | MyNicNaxs, Inc. |
| Jan 24, 2014 | Meizi Evolution Soft Gel Capsules, supplied in 30 count bottles, distributed ... | Marketed Without an Approved NDA/ANDA: Product was found to contain undeclared active pharmaceuti... | Class I | MyNicNaxs, Inc. |
| Jan 24, 2014 | Teva Dextroamphetamine Saccharate, Amphetamine Asparate, Dextroamphetamine Su... | CGMP Deviations: Dextroamphetamine Saccharate, Amphetamine Asparate, Dextroamphetamine Sulfate an... | Class II | Teva Pharmaceuticals USA |
| Jan 24, 2014 | Pill for weight reduction, (Japanese Chinese Formula from Japan Hokkaido Cang... | Marketed Without an Approved NDA/ANDA: Product was found to contain undeclared active pharmaceuti... | Class I | MyNicNaxs, Inc. |
| Jan 24, 2014 | SlimEasy Herbs Capsule, 400 mg, supplied in 30 count boxes, distributed by My... | Marketed Without an Approved NDA/ANDA: Product was found to contain undeclared active pharmaceuti... | Class I | MyNicNaxs, Inc. |
| Jan 24, 2014 | Teva Ethambutol Hydrochloride Tablets, USP, 400 mg, 100- count bottle, Rx Onl... | CGMP Deviations: Ethambutol Hydrochloride Tablets, USP, 400 mg were manufactured using unapproved... | Class II | Teva Pharmaceuticals USA |
| Jan 24, 2014 | JIANFEIJINDAN Activity Girl Capsules, 400 mg, supplied in 30 count boxes, dis... | Marketed Without an Approved NDA/ANDA: Product was found to contain undeclared ingredient: N-di-d... | Class I | MyNicNaxs, Inc. |
| Jan 24, 2014 | Teva Hydroxyzine Pamoate Capsules, USP, 25 mg, 100- count bottle, Rx Only,Dis... | CGMP Deviations: Hydroxyzine Pamoate Capsules, USP, 25 mg were manufactured using an unapproved m... | Class II | Teva Pharmaceuticals USA |
| Jan 24, 2014 | Super Fat Burning Bomb Capsules, 400 mg, supplied in 30 count boxes, distribu... | Marketed Without an Approved NDA/ANDA: Product was found to contain undeclared active pharmaceuti... | Class I | MyNicNaxs, Inc. |
| Jan 24, 2014 | REDUCE WEIGHT FRUTA PLANTA Capsules, 400 mg, supplied in 30 count boxes, dist... | Marketed Without an Approved NDA/ANDA: Product was found to contain undeclared active pharmaceuti... | Class I | MyNicNaxs, Inc. |
| Jan 24, 2014 | Magic Slim capsules, supplied in 60 count bottles, distributed by MyNicKnaxs,... | Marketed Without an Approved NDA/ANDA: Product was found to contain undeclared active pharmaceuti... | Class I | MyNicNaxs, Inc. |
| Jan 24, 2014 | Slim Xtreme Weight loss capsules, 500 mg, supplied in 30 count bottles, Anoth... | Marketed Without an Approved NDA/ANDA: Product was found to contain undeclared active pharmaceuti... | Class I | MyNicNaxs, Inc. |
| Jan 22, 2014 | Heparin Sodium Injection, USP 10,000 USP units per 10 mL (1,000 USP units per... | Subpotent; 18 month time point | Class II | Fresenius Kabi USA, LLC |
| Jan 16, 2014 | ROHTO Cooling Eye Drops, Itch Relief, Soothes Itch & Burn, relief, Astringent... | Lack of Assurance of Sterility: The Mentholatum Company has recalled Rohto Arctic, Rohto Ice, Roh... | Class II | The Mentholatum Co. |
| Jan 16, 2014 | ROHTO Dry Eye, hydra, Lubricant Eye Drops, Sterile, Net. Wt. 0.4 FL OZ (13 mL... | Lack of Assurance of Sterility: The Mentholatum Company has recalled Rohto Arctic, Rohto Ice, Roh... | Class II | The Mentholatum Co. |
| Jan 16, 2014 | ROHTO Redness Relief, arctic, Redness Reliever, Lubricant Eye Drops, Sterile,... | Lack of Assurance of Sterility: The Mentholatum Company has recalled Rohto Arctic, Rohto Ice, Roh... | Class II | The Mentholatum Co. |
| Jan 16, 2014 | Atorvastatin Calcium Tablets, 10 mg, 90-count tablets per bottle, Rx only, Ma... | Presence of Foreign Tablets: A product complaint was received by a pharmacist who discovered an A... | Class II | Ranbaxy Inc. |
| Jan 16, 2014 | ROHTO Redness Relief, ice, Redness Reliever, Lubricant, Astringent Eye Drops,... | Lack of Assurance of Sterility: The Mentholatum Company has recalled Rohto Arctic, Rohto Ice, Roh... | Class II | The Mentholatum Co. |
| Jan 16, 2014 | ROHTO Redness Relief, Cool, Redness Reliever, Lubricant Eye Drops, Sterile, N... | Lack of Assurance of Sterility: The Mentholatum Company has recalled Rohto Arctic, Rohto Ice, Roh... | Class II | The Mentholatum Co. |
| Jan 15, 2014 | Hydrocodone Bitartrate and Acetaminophen Tablets USP, CIII, 10 mg/ 660 mg, 10... | Failed Tablet/Capsule Specifications; Product contains broken tablets. | Class II | Watson Laboratories Inc |
| Jan 14, 2014 | Levothyroxine Sodium Tablets, USP, 200 mcg, 100-count bottle, Rx only, Distri... | Subpotent Drug: Assay results obtained during stability testing for Levothyroxine Sodium Tablets,... | Class II | Mylan Pharmaceuticals Inc. |
| Jan 14, 2014 | Guaifenesin USP, 50 Kg Drums, CAS No. 93-14-1, Reg. No. 05436, Caution: For M... | Presence of Foreign Matter: Guaifenesin API powder is being recalled due to the possibility that ... | Class II | Traxx International Corp |
| Jan 13, 2014 | Liptruzet (ezetimibe and atorvastin) tablets,10 mg/40 mg, a) 30 count blister... | This recall of LIPTRUZET is being initiated due to packaging defects. Some of the outer laminate... | Class III | Merck & Co Inc |
| Jan 13, 2014 | PRO ArthMax Dietary Supplement tablets, 750 mg, 120 count bottles, Distribute... | Marketed without an Approved NDA/ANDA; FDA analysis found the product to contain Chlorzoxazone, N... | Class I | HUMAN SCIENCE FOUNDATION |
| Jan 13, 2014 | Liptruzet (ezetimibe and atorvastin) tablets,10 mg/20 mg, a) 30 count blister... | This recall of LIPTRUZET is being initiated due to packaging defects. Some of the outer laminate... | Class III | Merck & Co Inc |
| Jan 13, 2014 | Liptruzet (ezetimibe and atorvastin) tablets,10 mg/10 mg, a) 30 count blister... | This recall of LIPTRUZET is being initiated due to packaging defects. Some of the outer laminate... | Class III | Merck & Co Inc |
| Jan 13, 2014 | Liptruzet (ezetimibe and atorvastin) tablets,10 mg/80 mg, a) 30 count blister... | Defective Container; some of the outer laminate foil pouches allowed in air and moisture, which c... | Class III | Merck & Co Inc |
| Jan 10, 2014 | Dermamedics Post Procedure Cream, 1 ounce containers which were distributed w... | Marketed without an Approved NDA/ANDA: FDA has determined that the products are unapproved new dr... | Class II | Dermamedics, L.L.C. |
| Jan 10, 2014 | DOBUTamine Injection, USP, 250 mg per 20 mL, 20 mL Single-dose Fliptop Vial, ... | Presence of Particulate Matter: Discolored solution due to a chip in the glass at the neck of the... | Class I | Hospira Inc. |
| Jan 10, 2014 | Dermamedics Complexion Repair Topical Rehydrating Emulsion which was distribu... | Marketed without an Approved NDA/ANDA: FDA has determined that the products are unapproved new dr... | Class II | Dermamedics, L.L.C. |
| Jan 10, 2014 | Dermamedics Calm and Correct Cream 2 oz. containers in the Dermamedics Post M... | Marketed without an Approved NDA/ANDA: FDA has determined that the products are unapproved new dr... | Class II | Dermamedics, L.L.C. |
| Jan 10, 2014 | Dermamedics Baby's Relief Calm and Repair Cream in 2 oz. containers with a SK... | Marketed without an Approved NDA/ANDA: FDA has determined that the products are unapproved new dr... | Class II | Dermamedics, L.L.C. |
| Jan 10, 2014 | Therametics Complexion Repair Topical Rehydrating Emulsion in 50 ml and 30 ml... | Marketed without an Approved NDA/ANDA: FDA has determined that the products are unapproved new dr... | Class II | Dermamedics, L.L.C. |
| Jan 10, 2014 | Dermamedics Calm & Correct Cream in 2 oz. containers with SKU number DM1020. | Marketed without an Approved NDA/ANDA: FDA has determined that the products are unapproved new dr... | Class II | Dermamedics, L.L.C. |
| Jan 10, 2014 | Dermamedics Complexion Repair Topical Rehydrating Emulsion in 50 ml and 30 ml... | Marketed without an Approved NDA/ANDA: FDA has determined that the products are unapproved new dr... | Class II | Dermamedics, L.L.C. |
| Jan 10, 2014 | Dermamedics Post Procedure Cream 1 oz. containers in the Dermamedics Post-Las... | Marketed without an Approved NDA/ANDA: FDA has determined that the products are unapproved new dr... | Class II | Dermamedics, L.L.C. |
| Jan 10, 2014 | Dermamedics Calm and Correct Serum, 2 oz. containers with a SKU number of BB1... | Marketed without an Approved NDA/ANDA: FDA has determined that the products are unapproved new dr... | Class II | Dermamedics, L.L.C. |
| Jan 9, 2014 | SEXY MONKEY, 2000 mg, 1 count blister, Distributed by A Herbal Bio, Inc., Bay... | Marketed Without an Approved NDA/ANDA: These dietary supplements contain undeclared sildenafil, a... | Class I | Schindele Enterprises dba Midwest Wholesale |
| Jan 9, 2014 | XZONE GOLD, 1 capsule blister 750 mg, Distributed by: XZONE, Orlando, FL. | Marketed Without an Approved NDA/ANDA: These dietary supplements contain undeclared sildenafil, a... | Class I | Schindele Enterprises dba Midwest Wholesale |
Frequently Asked Questions
When a drug safety issue is identified — through FDA inspections, laboratory testing, adverse event reports, or manufacturer quality checks — the responsible company issues a recall to remove the affected products from the market. Pharmacies pull the product from shelves, and consumers are advised to contact their healthcare provider for alternatives.
The leading causes include cGMP deviations, impurity contamination (including nitrosamines like NDMA), failed dissolution or stability testing, sterility issues, potency problems, labeling errors, and foreign particle contamination.
Use the search and filter tools on this page to look up specific medications, active ingredients, or manufacturers. Each recall entry includes the product description, lot numbers, and distribution details.